81627Y0870-INSTI HIV-1/2 Test kits and INSTI Control Test kits

The New York City Department of Health and Mental Hygiene is issuing an RFI inviting qualified vendors to submit an Expression of Interest for the supply of INSTI® HIV‑1/HIV‑2 Rapid Antibody Test kits (product code 90‑1019) and the matching test controls (product code 90‑1031). The city plans to procure these items on an as‑needed basis for its Field Services Unit and STD clinics across NYC, with an anticipated six‑year contract term. Vendors must be able to legally provide the FDA‑approved, CLIA‑waived rapid HIV test kits and controls, and must be prepared to meet the city’s inventory‑type demand. The deadline for EOI submission is 2 PM on October 30, 2026. • Products: INSTI® HIV‑1/HIV‑2 Rapid Antibody Test (90‑1019) and corresponding Test Controls (90‑1031). • Intended use: Rapid, point‑of‑care HIV antibody detection in NYC STD clinics and field‑service sites. • Contract length: Approx. six years (July 2027 – June 2033) with an estimated procurement value of about $9.65 million. • Eligibility: Any firm that can legally supply the listed products; no pre‑qualified list or mandatory pre‑bid meeting. • Submission: EOI must be entered through the PASSPort system by the stated deadline; technical assistance via the MOCS Service Desk.